Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[High dose rate prostate brachytherapy].

Nickers P, Blanchard P, Hannoun-Lévi JM, Bossi A, Chapet O, Guérif S.

Cancer Radiother. 2013 Apr;17(2):118-24. doi: 10.1016/j.canrad.2013.02.005. Review. French.

PMID:
23578898
2.

[Prostate cancer brachytherapy].

Pommier P, Guérif S, Peiffert D, Créhange G, Hannoun-Lévi JM, de Crevoisier R.

Cancer Radiother. 2016 Sep;20 Suppl:S210-5. doi: 10.1016/j.canrad.2016.07.038. French.

PMID:
27523412
3.

[Prostate cancer external beam radiotherapy].

de Crevoisier R, Pommier P, Latorzeff I, Chapet O, Chauvet B, Hennequin C.

Cancer Radiother. 2016 Sep;20 Suppl:S200-9. doi: 10.1016/j.canrad.2016.07.037. French.

PMID:
27516051
4.

Brachytherapy for clinically localized prostate cancer: optimal patient selection.

Kollmeier MA, Zelefsky MJ.

Arch Esp Urol. 2011 Oct;64(8):847-57. Review. English, Spanish.

PMID:
22052766
5.

High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity.

Yoshioka Y, Nose T, Yoshida K, Oh RJ, Yamada Y, Tanaka E, Yamazaki H, Inoue T, Inoue T.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):213-20.

PMID:
12694841
6.

The role of brachytherapy in the definitive management of prostate cancer.

Crook J.

Cancer Radiother. 2011 Jun;15(3):230-7. doi: 10.1016/j.canrad.2011.01.004. Review.

PMID:
21514199
7.

[Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].

Cosset JM, Hannoun-Lévi JM, Peiffert D, Delannes M, Pommier P, Pierrat N, Nickers P, Thomas L, Chauveinc L.

Cancer Radiother. 2013 Apr;17(2):111-7. doi: 10.1016/j.canrad.2013.01.009. Review. French.

PMID:
23478488
8.

Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.

Martinez A, Gonzalez J, Stromberg J, Edmundson G, Plunkett M, Gustafson G, Brown D, Yan D, Vicini F, Brabbins D.

Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1019-27.

PMID:
7493828
9.
10.

High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.

Jo Y, Hiratsuka J, Fujii T, Takenaka A, Fujisawa M.

Urology. 2004 Sep;64(3):556-60.

PMID:
15351592
11.

Minimizing prostate brachytherapy-related morbidity.

Merrick GS, Wallner KE, Butler WM.

Urology. 2003 Nov;62(5):786-92. Review. No abstract available.

PMID:
14624895
12.

[Prostate cancer: doses and volumes of radiotherapy].

Hennequin C, Rivera S, Quero L, Latorzeff I.

Cancer Radiother. 2010 Oct;14(6-7):474-8. doi: 10.1016/j.canrad.2010.07.229. Review. French.

PMID:
20728390
13.

Potency after permanent prostate brachytherapy for localized prostate cancer.

Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1235-42.

PMID:
11483334
14.

Radiation therapy for the treatment of locally advanced and metastatic prostate cancer.

Thurman SA, Ramakrishna NR, DeWeese TL.

Hematol Oncol Clin North Am. 2001 Jun;15(3):423-43. Review.

PMID:
11525289
15.

[What is the level of evidence of new techniques in prostate cancer radiotherapy?].

Khadige M, Peiffert D, Supiot S.

Cancer Radiother. 2014 Oct;18(5-6):501-8. doi: 10.1016/j.canrad.2014.06.021. Review. French.

PMID:
25192625
16.

Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?

Créhange G, Roach M 3rd, Martin E, Cormier L, Peiffert D, Cochet A, Chapet O, Supiot S, Cosset JM, Bolla M, Chung HT.

Cancer Radiother. 2014 Oct;18(5-6):524-34. doi: 10.1016/j.canrad.2014.07.153. Review. Erratum in: Cancer Radiother. 2014 Dec;18(8):806.

PMID:
25192626
17.

The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate.

Whittington R, Broderick GA, Arger P, Malkowicz SB, Epperson RD, Arjomandy B, Kassaee A.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1107-10.

PMID:
10421544
18.

Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.

Stromberg J, Martinez A, Gonzalez J, Edmundson G, Ohanian N, Vicini F, Hollander J, Gustafson G, Spencer W, Yan Di, et al.

Int J Radiat Oncol Biol Phys. 1995 Aug 30;33(1):161-71.

PMID:
7543891
19.

A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.

Hermesse J, Biver S, Jansen N, Lenaerts E, De Patoul N, Vynckier S, Coucke P, Scalliet P, Nickers P.

Strahlenther Onkol. 2009 Nov;185(11):736-42. doi: 10.1007/s00066-009-2009-5.

PMID:
19899007
20.

Combining external beam radiotherapy with prostate brachytherapy: issues and rationale.

Febles C, Valicenti RK.

Urology. 2004 Nov;64(5):855-61. Review. No abstract available.

PMID:
15533463
Items per page

Supplemental Content

Support Center